RedHill Biopharma Ltd.
Develops oral drugs for GI, infectious diseases, and pandemic preparedness.
RDHL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7574681034
- LEI:
- Country:
- United States of America
- Address:
- 21 HA'ARBA'A STREET, 64739 TEL AVIV
- Website:
- https://www.redhillbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
RedHill Biopharma Ltd. is a specialty biopharmaceutical company focused on developing and commercializing proprietary drugs to address significant unmet medical needs, primarily in gastrointestinal (GI) and infectious diseases. The company advances a pipeline of late-stage, oral, small molecule therapies. A key initiative is its pandemic preparedness and medical countermeasures program, which develops novel, broad-acting, host-directed therapies with intrinsic viral mutation-resistant properties suitable for stockpiling and rapid deployment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all RedHill Biopharma Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RedHill Biopharma Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RedHill Biopharma Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
